Mereo BioPharma Group Plc (MREO)
2.22
-0.03
(-1.33%)
USD |
NASDAQ |
Dec 12, 12:42
Mereo BioPharma Group Free Cash Flow: -33.02M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Adaptimmune Therapeutics Plc | -193.83M |
| Biodexa Pharmaceuticals Plc | -14.30M |
| NuCana Plc | -18.19M |
| Autolus Therapeutics Plc | -306.93M |
| Bicycle Therapeutics Plc | -242.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.256M |
| Cash from Investing (Quarterly) | 0.3027M |
| Cash from Financing (Quarterly) | -0.0014M |
| Free Cash Flow Per Share (Quarterly) | -0.0453 |
| Free Cash Flow to Equity (Quarterly) | -7.050M |
| Free Cash Flow to Firm (Quarterly) | -7.228M |
| Free Cash Flow Yield | -9.42% |